Loading…
Strengthening America's Strategic National Stockpile Act of 2020
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
89pct
71d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Strengthening America's Strategic National Stockpile Act of 2020 This bill makes changes to the administration and management of the Strategic National Stockpile. Among these changes, the bill authorizes through September 30, 2023, the Department of Health and Human Services (HHS) to transfer supplies from the stockpile to any federal departments or agencies under certain conditions. HHS must also ensure the contents of the stockpile remain in working order and may enter into maintenance service contracts to carry out this requirement. Furthermore, as part of its management of the stockpile, HHS must establish and maintain domestic reserves of certain supplies, including by entering into cooperative agreements or partnerships to access facilities and equipment to produce these supplies. The authority for such agreements and partnerships terminates on September 30, 2023. Additionally, the bill temporarily authorizes HHS to award grants to states for maintaining stockpiles of certain equipment and supplies for use during public health emergencies. HHS must also develop transparent processes for the use and distribution of supplies from the stockpile that address, for example, the prioritization of requests. Additionally, during the COVID-19 (i.e., coronavirus disease 2019) emergency, the Office of the Assistant Secretary for Preparedness and Response must report monthly on requests for supplies from states, tribes, and other jurisdictions. These reports must include the rationale for any partially fulfilled or denied requests. Lastly, the Government Accountability Office must study the feasibility of establishing user fees to offset costs for procuring single-source materials for, and distributing such materials from, the stockpile.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (17)
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4618-4620)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
DEBATE - The House proceeded with forty minutes of debate on H.R. 7574.
Considered under suspension of the rules. (consideration: CR H4618-4620)
Mrs. Dingell moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 418.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-518.
Congress.gov source codes: 5000, H12200
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2020 · fourth_quarter · Health Issues
HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. S 2543 - Prescription Drug Pricing Reduction Act of 2019. S 551 - Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 HR 5238 - Better and Robust Screening Today Act S 2955 - Better and Robust Screening Today Act HR 3224 Deborah Sampson Act S 3343 - Medical Supply Chain Security Act S 3468 - Preventing Essential Medical Device Shortages Act of 2020 COVID-19 response Energy and Water Appropriations Health and Human Services Appropriations Healthcare trade HR 7574 - Strengthening America's Strategic National Stockpile Act of 2020 HR 7956 - Critical Medical Infrastructure Right-to-Repair Act of 2020 S 4473 - Critical Medical Infrastructure Right-to-Repair Act of 2020 Health Care Cybersecurity
Client expense: $1,010,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2020 · fourth_quarter · Health Issues
HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. S 2543 - Prescription Drug Pricing Reduction Act of 2019. S 551 - Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 HR 5238 - Better and Robust Screening Today Act S 2955 - Better and Robust Screening Today Act HR 3224 Deborah Sampson Act S 3343 - Medical Supply Chain Security Act S 3468 - Preventing Essential Medical Device Shortages Act of 2020 COVID-19 response Energy and Water Appropriations Health and Human Services Appropriations Healthcare trade HR 7574 - Strengthening America's Strategic National Stockpile Act of 2020 HR 7956 - Critical Medical Infrastructure Right-to-Repair Act of 2020 S 4473 - Critical Medical Infrastructure Right-to-Repair Act of 2020 Health Care Cybersecurity
Client expense: $940,000 · Firm income: Not reported
2020 · fourth_quarter · Labor Issues/Antitrust/Workplace
Lobbied on the confirmations of Chad Bungard, Dennis Dean Kirk, and Julia Clark to serve on the MSPB. Lobbied against confirmation of Catherine Bird to be General Counsel of FLRA. Lobbied against confirmation of John Gibbs to be director of the Office of Personnel Management. Lobbied against any attempts the expand the Department of Veterans Affairs' Accountability and Whistleblower Protection Act government-wide. Lobbied in support of H.R. 1254, the "Equal COLA Act," to achieve parity between the cost of living adjustment to an annuity under the Federal Employees Retirement System and an annuity under the Civil Service Retirement System. Lobbied in support of S. 165, the "Federal Unemployment Compensation Equality Act of 2019," to amend current law to clarify that Federal employees excepted from a furlough are eligible for unemployment compensation. Lobbied in support of S. 222, to require payment of interest on back pay for employees affected by a lapse in appropriations. Lobbied in support of H.R. 953, to help prevent negative credit reporting due to a government shutdown. Lobbied in support of S. 464, Protecting Employees' Security Clearances Act (PESCA), which requires consideration of a lapse in appropriations as a mitigating condition when assessing financial consideration for security clearances. Lobbied in support of H.R. 5690/S. 3231, the "Federal Adjustment of Income Rates Act" to provide federal employees with a 3.5% salary adjustment in 2021. Lobbied in support of S. 521 and H.R. 141, Social Security Fairness Act, to repeal the government pension offset and windfall elimination provisions. Lobbied in support of S. 530 and H.R. 1316, the "Federal Labor-Management Partnership Act," to establish the Federal Labor-Management Partnership Council. Lobbied in support of S. 24, Government Employee Fair Treatment Act of 2019, so employees of the federal government or a District of Columbia public employer who are furloughed or required to work during a lapse in appropriations beginning on or after December 22, 2018, to be compensated for the period of the lapse. Lobbied in support of H.R. 7, the "Paycheck Fairness Act," To amend the "Fair Labor Standards Act of 1938" to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex, and for other purposes. Lobbied against H.R. 605, Official Time Reporting Act, to require that the Office of Personnel Management submit an annual report to Congress relating to the use of official time by Federal employees. Lobbied for H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act, to require DOL to address workplace violence in the health care and social service sectors Lobbied for H.R. 582, Raise the Wage Act, to increase the federal minimum wage for regular employees over a 7-year period, for tipped employees, and for newly hired employees who are less than 20 years old. Lobbied in support of H.R. 4328, the "Protecting Innocent Consumers Affected by the Shutdown Act of 2019." Lobbied Education and Labor Committee on collective bargaining contract effects on the Education workforce and Secretary's actions to alter the Department's work on student loans and civil rights enforcement. Lobbied in support of H.R. 3463/S. 1970, the "Public Service Freedom to Negotiated Act." Lobbied in support of H.R. 2474/S. 1306, the "Protecting the Right to Organize Act." Lobbied against the nomination of Keith Sonderling (R) and Andrea Lucas (R) nominees for the EEOC. Lobbied in support of Jocelyn Samuels (D) nominee for the EEOC. Lobbied for passage of H.R. 7574, the "Strengthening America's Strategic National Stockpile Act of 2020." FY 2020 Emergency Supplemental Coronavirus Pandemic Response Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 925, the Heroes Act; H.R. 8015, the Delivering for America Act; and H.R. 8319, the FY 2020 Continuing Appropriations and Other Extensions Act. FY 2020 Supplemental Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 8900 making continuing appropriations for FY 2020 through December 18, 2020. Lobbied for passage of H.J.Res. 107, making continuing appropriations for FY 2020 through December 20, 2020; lobbied for passage of H.J.Res. 110, making continuing appropriations for FY 2020 through December 21, 2020; lobbied for passage of H.R. 1520, making continuing appropriations for FY 2020 through December 28, 2020. FY 2021 Omnibus Appropriations, H.R. 133 - Lobbied for passage of and inclusion of emergency coronavirus pandemic response provisions for FY 2021, including hazard pay, presumption of workplace illness for frontline employees who contract Covid-19, an OSHA emergency standard and additional PPE and resources to distribute the vaccine to federal workers.
2020 · fourth_quarter · Health Issues
HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. S 2543 - Prescription Drug Pricing Reduction Act of 2019. S 551 - Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 HR 5238 - Better and Robust Screening Today Act S 2955 - Better and Robust Screening Today Act HR 3224 Deborah Sampson Act S 3343 - Medical Supply Chain Security Act S 3468 - Preventing Essential Medical Device Shortages Act of 2020 COVID-19 response Energy and Water Appropriations Health and Human Services Appropriations Healthcare trade HR 7574 - Strengthening America's Strategic National Stockpile Act of 2020 HR 7956 - Critical Medical Infrastructure Right-to-Repair Act of 2020 S 4473 - Critical Medical Infrastructure Right-to-Repair Act of 2020 Health Care Cybersecurity
Client expense: $940,000 · Firm income: Not reported
2020 · fourth_quarter · Disaster Planning/Emergencies
Access to emergency medical supplies (including Personal Protective Equipment, COVID-19 tests, ventilators, and medications) during COVID-19 national emergency Implementation of the Defense Production Act during the COVID-19 national emergency H.R.451-Dont Break Up the T-Band Act of 2020 H.R.925-The Heroes Act H.R.2550-Prevent Blood Loss with Emergency Equipment Devices Act of 2019 H.R.6800-Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R.6930-Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 H.R.7574-Strengthening Americas Strategic National Stockpile Act of 2020 H.R.8441-Frontlines Heroes Act S.3346-Prevent Blood Loss with Emergency Equipment Devices Act of 2020
Client expense: $340,838 · Firm income: Not reported
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| House |
| Referred to |
| July 13, 2020 |
| July 13, 2020 |
| Democratic |
| FL |
| David B. McKinley | Republican | WV |
| Debbie Dingell | Democratic | MI |
| Diana DeGette | Democratic | CO |
| Earl L. "Buddy" Carter | Republican | GA |
| Fred Upton | Republican | MI |
| G. K. Butterfield | Democratic | NC |
| Gilbert Ray Cisneros, Jr. | Democratic | CA |
| Greg Gianforte | Republican | MT |
| Jackie Walorski | Republican | IN |
| Jefferson Van Drew | Republican | NJ |
| Joe Neguse | Democratic | CO |
| Kim Schrier | Democratic | WA |
| Michael C. Burgess | Republican | TX |
| Richard Hudson | Republican | NC |
| Susan W. Brooks | Republican | IN |
| Tom Malinowski | Democratic | NJ |
| HR 6877 |
116th |
| Related bill |
| HR 6876 | 116th | Related bill |
| HR 6875 | 116th | Related bill |
| HR 6531 | 116th | Related bill |
| HR 6517 | 116th | Related bill |
| HR 14 | 116th | Related bill |
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Aeronautics & Space Administration (NASA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Client expense: $480,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Air Force, Dept of, Army, Dept of (Corps of Engineers), Army, Dept of (Other), Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense Commissary Agency, Defense Contract Audit Agency (DCAA), Defense Finance & Accounting Service (DFAS), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Coast Guard (USCG), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Marines, Veterans Affairs, Dept of (VA), Voice of America
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Aeronautics & Space Administration (NASA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Price transparency, out-of-network reimbursement of emergency medical services, surprise medical bills Opioids, pain management Federal funding for Substance Use Disorder treatments Drug Shortages H.R.451-Dont Break Up the T-Band Act of 2020 H.R.501-Poison Center Network Enhancement Act of 2019 H.R.861-End Surprise Billing Act of 2019 H.R.925-The Heroes Act H.R.1301-Mental Health Telemedicine Expansion Act H.R.1309-Workplace Violence Prevention for Health Care and Social Service Workers Act H.R.1418-Competitive Health Insurance Reform Act of 2019 H.R.1554-Resident Education Deferred Interest (REDI) Act H.R.1646-Helping Emergency Responders Overcome (HERO) Act H.R.1682-Improving Access to Medicare Coverage Act of 2019 H.R.1767-Excellence in Mental Health and Addiction Treatment Expansion Act H.R.2281-Easy Medication Access and Treatment (MAT) for Opioid Addiction Act H.R.2328-Reauthorizing and Extending Americas Community Health Act H.R.2464-End the Cycle of Violence Act of 2019 H.R.2482-Mainstreaming Addiction Treatment Act of 2019 H.R.2519-Improving Mental Health Access from the Emergency Department Act of 2019 H.R.2550-Prevent Blood Loss with Emergency Equipment Devices Act of 2019 H.R.2569-Comprehensive Addiction Resources Emergency Act of 2019 H.R.3107-Improving Seniors Timely Access to Care Act of 2019 H.R.3417-Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019 H.R.3502-Protecting People From Surprise Medical Bills Act H.R.3630-No Surprises Act H.R.3935-Protecting Patients Transportation to Care Act H.R.3984-Health Care Safety Net Enhancement Act of 2019 H.R.4194-National Suicide Hotline Designation Act of 2019 H.R.4861-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 H.R.4932-Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2019 H.R.5619-Suicide Prevention Act H.R.5727-Research Empirical Solutions to End Ambulance Reversals from Closed Hospitals (RESEARCH) Act of 2020 H.R.5800-Ban Surprise Billing Act H.R.5826-Consumer Protections Against Surprise Medical Bills Act of 2020 H.R.5855-Bipartisan Solution to Cyclical Violence Act of 2020 H.R.6663-Truth in Healthcare Marketing Act of 2020 H.R.6800-Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R.6910-Emergency Room Hero and Patient Safety Act H.R.6930-Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 H.R.7059-Coronavirus Provider Protection Act H.R.7255-Coronavirus Health Care Worker Wellness Act of 2020 H.R.7574-Strengthening Americas Strategic National Stockpile Act of 2020 H.R.7819-Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.8094-Dr. Lorna Breen Health Care Provider Protection Act H.R.8441-Frontlines Heroes Act H.R.8505-To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes H.R.8702-Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020 S.289-Rural Physician Workforce Production Act of 2019 S.299-Geriatrics Workforce Improvement Act S.350-Competitive Health Insurance Reform Act of 2019 S.618-Medicare Choices Empowerment and Protection Act S.753-Improving Access to Medicare Coverage Act of 2019 S.824-Excellence in Mental Health and Addiction Treatment Expansion Act S.851-Workplace Violence Prevention for Health Care and Social Service Workers Act S.1199-Poison Center Network Enhancement Act of 2019 S.1266-Protecting Patients from Surprise Medical Bills Act S.1334-Improving Mental Health Access from the Emergency Department S.1350-Good Samaritan Health Professionals Act of 2019 S.1365-Comprehensive Addiction Resources Emergency Act of 2019 S.1531-Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1895-Lower Health Care Costs Act S.2074-Mainstreaming Addiction Treatment Act of 2019 S.2661-National Suicide Hotline Designation Act of 2020 S.2741-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S.3006-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 S.3143-Magnet Injury Prevention Act S.3198-Suicide Prevention Act S.3346-Prevent Blood Loss with Emergency Equipment Devices Act of 2020 S.4349-Dr. Lorna Breen Health Care Provider Protection Act S.5007-Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
Client expense: $340,838 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Price transparency, out-of-network reimbursement of emergency medical services, surprise medical bills Opioids, pain management Federal funding for Substance Use Disorder treatments Drug Shortages H.R.451-Dont Break Up the T-Band Act of 2020 H.R.501-Poison Center Network Enhancement Act of 2019 H.R.861-End Surprise Billing Act of 2019 H.R.925-The Heroes Act H.R.1301-Mental Health Telemedicine Expansion Act H.R.1309-Workplace Violence Prevention for Health Care and Social Service Workers Act H.R.1418-Competitive Health Insurance Reform Act of 2019 H.R.1554-Resident Education Deferred Interest (REDI) Act H.R.1646-Helping Emergency Responders Overcome (HERO) Act H.R.1682-Improving Access to Medicare Coverage Act of 2019 H.R.1767-Excellence in Mental Health and Addiction Treatment Expansion Act H.R.2281-Easy Medication Access and Treatment (MAT) for Opioid Addiction Act H.R.2328-Reauthorizing and Extending Americas Community Health Act H.R.2464-End the Cycle of Violence Act of 2019 H.R.2482-Mainstreaming Addiction Treatment Act of 2019 H.R.2519-Improving Mental Health Access from the Emergency Department Act of 2019 H.R.2550-Prevent Blood Loss with Emergency Equipment Devices Act of 2019 H.R.2569-Comprehensive Addiction Resources Emergency Act of 2019 H.R.3107-Improving Seniors Timely Access to Care Act of 2019 H.R.3417-Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019 H.R.3502-Protecting People From Surprise Medical Bills Act H.R.3630-No Surprises Act H.R.3935-Protecting Patients Transportation to Care Act H.R.3984-Health Care Safety Net Enhancement Act of 2019 H.R.4194-National Suicide Hotline Designation Act of 2019 H.R.4861-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 H.R.4932-Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act of 2019 H.R.5619-Suicide Prevention Act H.R.5727-Research Empirical Solutions to End Ambulance Reversals from Closed Hospitals (RESEARCH) Act of 2020 H.R.5800-Ban Surprise Billing Act H.R.5826-Consumer Protections Against Surprise Medical Bills Act of 2020 H.R.5855-Bipartisan Solution to Cyclical Violence Act of 2020 H.R.6663-Truth in Healthcare Marketing Act of 2020 H.R.6800-Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R.6910-Emergency Room Hero and Patient Safety Act H.R.6930-Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 H.R.7059-Coronavirus Provider Protection Act H.R.7255-Coronavirus Health Care Worker Wellness Act of 2020 H.R.7574-Strengthening Americas Strategic National Stockpile Act of 2020 H.R.7819-Eliminating the Provider Relief Fund Tax Penalties Act of 2020 H.R.8094-Dr. Lorna Breen Health Care Provider Protection Act S.289-Rural Physician Workforce Production Act of 2019 S.299-Geriatrics Workforce Improvement Act S.350-Competitive Health Insurance Reform Act of 2019 S.618-Medicare Choices Empowerment and Protection Act S.753-Improving Access to Medicare Coverage Act of 2019 S.824-Excellence in Mental Health and Addiction Treatment Expansion Act S.851-Workplace Violence Prevention for Health Care and Social Service Workers Act S.1199-Poison Center Network Enhancement Act of 2019 S.1266-Protecting Patients from Surprise Medical Bills Act S.1334-Improving Mental Health Access from the Emergency Department S.1350-Good Samaritan Health Professionals Act of 2019 S.1365-Comprehensive Addiction Resources Emergency Act of 2019 S.1531-Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1895-Lower Health Care Costs Act S.2074-Mainstreaming Addiction Treatment Act of 2019 S.2661-National Suicide Hotline Designation Act of 2020 S.2741-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019 S.3006-Effective Suicide Screening and Assessment in the Emergency Department Act of 2019 S.3143-Magnet Injury Prevention Act S.3198-Suicide Prevention Act S.3346-Prevent Blood Loss with Emergency Equipment Devices Act of 2020 S.4349-Dr. Lorna Breen Health Care Provider Protection Act
Client expense: $391,824 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Disaster Planning/Emergencies
Access to emergency medical supplies (including Personal Protective Equipment, COVID-19 tests, ventilators, and medications) during COVID-19 national emergency Implementation of the Defense Production Act during the COVID-19 national emergency H.R.451-Dont Break Up the T-Band Act of 2020 H.R.925-The Heroes Act H.R.2550-Prevent Blood Loss with Emergency Equipment Devices Act of 2019 H.R.6800-Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R.6930-Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 H.R.7574-Strengthening Americas Strategic National Stockpile Act of 2020 S.3346-Prevent Blood Loss with Emergency Equipment Devices Act of 2020
Client expense: $391,824 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Budget/Appropriations
State Opioid Response Grants funding for FY 2021 H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020 HEROES Act - H.R. 8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Homeland Security
State Opioid Response Grants funding for FY 2021 H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020 HEROES Act - H.R. 8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding for FY 2021 H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020 HEROES Act - H.R. 8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
COVID-19 pandemic response and supply chain issues; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531); FY 2021 National Defense Authorization Act (H.R. 6395); FY 2021 Consolidated Appropriations Act (H.R. 133).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Free Trade Agreements - Intellectual Property and Transparency Provisions - Free Trade Agreements China Agreement UK Agreement Intellectual Property Access to Medicines Issues Global Health Issues India, China and Canada IP and Market Access Issues Sub-standards Medicines Quality of Medicines International Market Access and Intellectual Property Issues Biopharmaceutical Innovation Policies Regulatory Cooperation USTR Special 301 Report/National Trade Estimate Trade Policy Tariffs CFIUS USMCA Pharmaceutical supply chain H.R. 2209 - Fixing Global Freeloading Act H.R. 6049 - Medical Supply Chain Security Act H.R. 6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020 H.R. 6690 - Bring Entrepreneurial Advancements To Consumers Here In North America Act H.R. 6731 - Securing America's Pharmaceutical Supply Chain Act H.R. 6879 - Buy American Medical Supply Chain Act of 2020 H.R. 7492 - To designate all of Puerto Rico as an opportunity zone H.R. 7505 - American Innovation Act of 2020: Provisions related to manufacturing tax incentives H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 H.R. 7955 - 21st Century Buy American Act S. 3343 - Medical Supply Chain Security Act S. 3478 - To establish a commission to assess, evaluate, and address the dependence of the United States on medications, devices, and medical equipment from foreign countries S. 3537 - A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes S. 3942 - Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act S. 3945 - A bill to amend the Internal Revenue Code of 1986 to provide incentives for relocating manufacturing of pharmaceuticals and medical supplies and devices to the United States H.R. 4710 - Pharmaceutical Independence Long-Term Readiness Reform Act H.R. 6393 - Strengthening America's Supply Chain and National Security Act H.R. 6930 - MADE in America Act of 2020 H.R. 8943 - Pandemic Supplies Production Act H.R. 8987 - Enhancing the Security of the U.S. Pharmaceutical Supply Chain Act of 2020 H.R. 8905 - Supply Chain Security and Pharmaceutical Authentication Act of 2020 S. 3635 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020 S. 4175 - Pharmaceutical Supply Chain Defense and Enhancement Act S. 4194 - National Institute of Manufacturing Act Pricing and reimbursement policy issues Supply chain and China Task Force policy issues
Client expense: $660,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Health Issues
COVID-19 pandemic response; issues related to the health care supply chain; Medical Supplies for Pandemics Act (H.R. 6531); Implementation of CARES Act (P.L. 116-136); Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); FY 2021 National Defense Authorization Act (H.R. 6395); CASH Act of 2020 (H.R. 9051); FY 2021 Consolidated Appropriations Act (H.R. 133).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2020 · fourth_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2020 · fourth_quarter · Health Issues
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2020 · fourth_quarter · Budget/Appropriations
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2020 · fourth_quarter · Disaster Planning/Emergencies
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2020 · fourth_quarter · Homeland Security
State Opioid Response Grants funding for FY 2021 H.R. 6395 The National Defense Authorization Act (NDAA) for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783 "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R. 8406 - The Heroes Act S. 4231 Preparing for the Next Pandemic Act HEALS Act H.R. 14 the Commitment to Defeat the Virus and Keep America Healthy Act H.R. 133, Consolidated Appropriations Act 2021
Client expense: $900,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2020 · fourth_quarter · Health Issues
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531); FY 2021 National Defense Authorization Act (H.R. 6395); FY 2021 Consolidated Appropriations Act (H.R. 133); Issues related to the health care supply chain and COVID-19 response.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2020 · fourth_quarter · Budget/Appropriations
Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to H.R. 925 - The Heroes Act; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020; Issues related to H.R. 133 Consolidated Appropriations Act, 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2020 · fourth_quarter · Disaster Planning/Emergencies
Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020; Issues related to H.R. 133 Consolidated Appropriations Act, 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2020 · fourth_quarter · Homeland Security
Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020; Issues related to H.R. 133 Consolidated Appropriations Act, 2021.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2020 · fourth_quarter · Health Issues
General issues related to drug shortages General issues related to COVID-19 (S. 3630, S. 4317, H.R. 7528) General issues related to drug cost oversight General issues related to domestic manufacturing of pharmaceutical products Lower Health Care Costs Act (S. 1895) Lower Drug Costs Now Act (H.R. 3) Prescription Drug Pricing Reduction Act (S. 2543) CARES Act (H.R. 748) Families First Coronavirus Response Act (H.R. 6201) HEROES Act (H.R. 6800) H.R. 133 - Consolidated Appropriations Act, 2021 General issues related to the Public Health Services Act Strengthening Americas Strategic National Stockpile Act of 2020 (H.R. 7574) Preparing for the Next Pandemic Act (S. 4231)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
General issues related to drug shortages General issues related to COVID-19 (S 3630, S 4317, HR 7528) General issues related to drug cost oversight General issues related to domestic manufacturing of pharmaceutical products General issues related to the Public Health Services Act Lower Health Care Costs Act (S 1895) Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act (S 2543) CARES Act (HR 748) Families First Coronavirus Response Act (HR 6201) HEROES Act (HR 6800) Strengthening America's Strategic National Stockpile Act of 2020 (HR 7574) Preparing for the Next Pandemic Act (S 4231)
Client expense: $285,896 · Firm income: Not reported
Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. S 2543 - Prescription Drug Pricing Reduction Act of 2019. S 551 - Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 HR 5238 - Better and Robust Screening Today Act S 2955 - Better and Robust Screening Today Act HR 3224 Deborah Sampson Act S 3343 - Medical Supply Chain Security Act S 3468 - Preventing Essential Medical Device Shortages Act of 2020 COVID-19 response Energy and Water Appropriations Health and Human Services Appropriations Healthcare trade HR 7574 - Strengthening America's Strategic National Stockpile Act of 2020 HR 7956 - Critical Medical Infrastructure Right-to-Repair Act of 2020 S 4473 - Critical Medical Infrastructure Right-to-Repair Act of 2020 Health Care Cybersecurity
Client expense: $940,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Aeronautics & Space Administration (NASA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2020 · fourth_quarter · Labor Issues/Antitrust/Workplace
Lobbied on the confirmations of Chad Bungard, Dennis Dean Kirk, and Julia Clark to serve on the MSPB. Lobbied against confirmation of Catherine Bird to be General Counsel of FLRA. Lobbied against confirmation of John Gibbs to be director of the Office of Personnel Management. Lobbied against any attempts the expand the Department of Veterans Affairs' Accountability and Whistleblower Protection Act government-wide. Lobbied in support of H.R. 1254, the "Equal COLA Act," to achieve parity between the cost of living adjustment to an annuity under the Federal Employees Retirement System and an annuity under the Civil Service Retirement System. Lobbied in support of S. 165, the "Federal Unemployment Compensation Equality Act of 2019," to amend current law to clarify that Federal employees excepted from a furlough are eligible for unemployment compensation. Lobbied in support of S. 222, to require payment of interest on back pay for employees affected by a lapse in appropriations. Lobbied in support of H.R. 953, to help prevent negative credit reporting due to a government shutdown. Lobbied in support of S. 464, Protecting Employees' Security Clearances Act (PESCA), which requires consideration of a lapse in appropriations as a mitigating condition when assessing financial consideration for security clearances. Lobbied in support of H.R. 5690/S. 3231, the "Federal Adjustment of Income Rates Act" to provide federal employees with a 3.5% salary adjustment in 2021. Lobbied in support of S. 521 and H.R. 141, Social Security Fairness Act, to repeal the government pension offset and windfall elimination provisions. Lobbied in support of S. 530 and H.R. 1316, the "Federal Labor-Management Partnership Act," to establish the Federal Labor-Management Partnership Council. Lobbied in support of S. 24, Government Employee Fair Treatment Act of 2019, so employees of the federal government or a District of Columbia public employer who are furloughed or required to work during a lapse in appropriations beginning on or after December 22, 2018, to be compensated for the period of the lapse. Lobbied in support of H.R. 7, the "Paycheck Fairness Act," To amend the "Fair Labor Standards Act of 1938" to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex, and for other purposes. Lobbied against H.R. 605, Official Time Reporting Act, to require that the Office of Personnel Management submit an annual report to Congress relating to the use of official time by Federal employees. Lobbied for H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act, to require DOL to address workplace violence in the health care and social service sectors Lobbied for H.R. 582, Raise the Wage Act, to increase the federal minimum wage for regular employees over a 7-year period, for tipped employees, and for newly hired employees who are less than 20 years old. Lobbied in support of H.R. 4328, the "Protecting Innocent Consumers Affected by the Shutdown Act of 2019." Lobbied Education and Labor Committee on collective bargaining contract effects on the Education workforce and Secretary's actions to alter the Department's work on student loans and civil rights enforcement. Lobbied in support of H.R. 3463/S. 1970, the "Public Service Freedom to Negotiated Act." Lobbied in support of H.R. 2474/S. 1306, the "Protecting the Right to Organize Act." Lobbied against the nomination of Keith Sonderling (R) and Andrea Lucas (R) nominees for the EEOC. Lobbied in support of Jocelyn Samuels (D) nominee for the EEOC. Lobbied for passage of H.R. 7574, the "Strengthening America's Strategic National Stockpile Act of 2020." FY 2020 Emergency Supplemental Coronavirus Pandemic Response Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 925, the Heroes Act; H.R. 8015, the Delivering for America Act; and H.R. 8319, the FY 2020 Continuing Appropriations and Other Extensions Act. FY 2020 Supplemental Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 8900 making continuing appropriations for FY 2020 through December 18, 2020. Lobbied for passage of H.J.Res. 107, making continuing appropriations for FY 2020 through December 20, 2020; lobbied for passage of H.J.Res. 110, making continuing appropriations for FY 2020 through December 21, 2020; lobbied for passage of H.R. 1520, making continuing appropriations for FY 2020 through December 28, 2020. FY 2021 Omnibus Appropriations, H.R. 133 - Lobbied for passage of and inclusion of emergency coronavirus pandemic response provisions for FY 2021, including hazard pay, presumption of workplace illness for frontline employees who contract Covid-19, an OSHA emergency standard and additional PPE and resources to distribute the vaccine to federal workers.
Client expense: $480,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Air Force, Dept of, Army, Dept of (Corps of Engineers), Army, Dept of (Other), Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense Commissary Agency, Defense Contract Audit Agency (DCAA), Defense Finance & Accounting Service (DFAS), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Coast Guard (USCG), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Marines, Veterans Affairs, Dept of (VA), Voice of America
2020 · fourth_quarter · Homeland Security
H.R. 133 - Consolidated Appropriations Act, 2021 - Division H, Title II, Department of Health and Human Services - provisions and funding for development, acquisition and stockpiling of medical countermeasures (MCM) and Division M, Coronavirus Response Supplemental Appropriations Act, 2021 - funding for COVID-19 vaccines/therapeutics and distribution; H.R. 6395 and S. 4049 - National Defense Authorization Act for Fiscal Year 2021 - provisions related to biological and chemical defense and access to Naloxone opioid reversal in military health system; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) - provisions related to the development, acquisition and stockpiling of medical countermeasures for the U.S. government; H.R. 8406 - The HEROES Act - Supplemental Stimulus Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government; Initiatives and products to combat the opioid health crisis, including naloxone access and prescribing guidelines; H.R. 2466 - State Opioid Response Grant Authorization Act - entire bill; S. 4058 - Emergency Support for Substance Use Disorders Act - emergency grants for states and community organizations serving individuals with substance use disorder; H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 - entire bill.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Disaster Planning/Emergencies
H.R. 133 - Consolidated Appropriations Act, 2021 - Division H, Title II, Department of Health and Human Services - provisions and funding for development, acquisition and stockpiling of medical countermeasures (MCM) and Division M, Coronavirus Response Supplemental Appropriations Act, 2021 - funding for COVID-19 vaccines/therapeutics and distribution; H.R. 6395 and S. 4049 - National Defense Authorization Act for Fiscal Year 2021 - provisions related to biological and chemical defense and access to Naloxone opioid reversal in military health system; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) - provisions related to the development, acquisition and stockpiling of medical countermeasures for the U.S. government; H.R. 8406 - The HEROES Act - Supplemental Stimulus Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government; Initiatives and products to combat the opioid health crisis, including naloxone access and prescribing guidelines; H.R. 2466 - State Opioid Response Grant Authorization Act - entire bill; S. 4058 - Emergency Support for Substance Use Disorders Act - emergency grants for states and community organizations serving individuals with substance use disorder; H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 - entire bill.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Budget/Appropriations
H.R. 133 - Consolidated Appropriations Act, 2021 - Division H, Title II, Department of Health and Human Services - provisions and funding for development, acquisition and stockpiling of medical countermeasures (MCM) and Division M, Coronavirus Response Supplemental Appropriations Act, 2021 - funding for COVID-19 vaccines/therapeutics and distribution; H.R. 6395 and S. 4049 - National Defense Authorization Act for Fiscal Year 2021 - provisions related to biological and chemical defense and access to Naloxone opioid reversal in military health system; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) - provisions related to the development, acquisition and stockpiling of medical countermeasures for the U.S. government; H.R. 8406 - The HEROES Act - Supplemental Stimulus Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government; Initiatives and products to combat the opioid health crisis, including naloxone access and prescribing guidelines; H.R. 2466 - State Opioid Response Grant Authorization Act - entire bill; S. 4058 - Emergency Support for Substance Use Disorders Act - emergency grants for states and community organizations serving individuals with substance use disorder; H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 - entire bill.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Defense
H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone HR 7574 - Strengthening America's Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy & Commerce)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Pharmacy
S. 2686 & H.R. 4814-Suspicious Order Identification Act of 2019; H.R. 4812-Ensuring Compliance Against Drug Diversion Act of 2019; H.R. 4806-Tthe Debarment Enforcement of Bad Actor Registrants Act of 2019; H.R. 3878-Block, Report And Suspend Suspicious Shipments Act of 2020; HR 7574-Strengthening America's Strategic National Stockpile Act of 2020.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Trade (domestic/foreign)
H.R. 2209: Fixing Global Freeloading Act - Provisions related to trade policy issues and international pharmaceutical drug pricing issues H.R. 4710: Pharmaceutical Independence Long-Term Readiness Reform Act - Provisions related to the supply chain H.R. 6049: Medical Supply Chain Security Act - Provisions related to prescription drug supply chains and drug safety H.R. 6482: Protecting Our Pharmaceutical Supply Chain from China Act of 2020 - Provisions related to prescription drug supply chains H.R. 6690: Bring Entrepreneurial Advancements To Consumers Here In North America Act - Provisions related to prescription drug supply chains and manufacturing tax incentives H.R. 6731: Securing America's Pharmaceutical Supply Chain Act - Provisions related to prescription drug supply chains H.R. 6879: Buy American Medical Supply Chain Act of 2020 - Provisions related to prescription drug and medical device supply chains H.R. 6930: MADE in America Act of 2020 - Provisions related prescription drug supply chains and manufacturing tax incentives H.R. 7492: To designate all of Puerto Rico as an opportunity zone - Provisions related to manufacturing incentives H.R. 7505: American Innovation Act of 2020: Provisions related to manufacturing tax incentives H.R. 7574: Strengthening America's Strategic National Stockpile Act of 2020 - Provisions related to medical supply chains H.R. 7955: 21st Century Buy American Act - Provisions related to federal domestic sourcing requirements S. 3343: Medical Supply Chain Security Act - Provisions related to prescription drug supply chains and drug safety S. 3478: To establish a commission to assess, evaluate, and address the dependence of the United States on medications, devices, and medical equipment from foreign countries - Provisions related to prescription drug supply chains and drug safety S. 3537: A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes - Provisions related to prescription drug supply chains and drug safety S. 3538: A bill to require the Secretary of Defense to submit to Congress a report on the reliance by the Department of Defense on imports of certain pharmaceutical products made in part or in whole in certain countries, to establish postmarket reporting requirements for pharmaceuticals, and for other purposes - Provisions related to prescription drug supply chains and drug safety S. 3635: Protecting Our Pharmaceutical Supply Chain from China Act of 2020 - Provisions related to prescription drug supply chains S. 3942: A bill to establish the position of Chief Pharmaceutical and Medical Supply Chain Negotiator in the Office of the United States Trade Representative, to be responsible for conducting trade negotiations and enforcing trade agreements related to acts, policies, and practices of foreign governments that fail to appropriately reward United States innovation with respect to pharmaceuticals, to advance domestic production of life-saving medicines, and to secure the United States medical supply chain to eliminate reliance on foreign governments, and for other purposes - Provisions related to prescription drug supply chains S. 3945: A bill to amend the Internal Revenue Code of 1986 to provide incentives for relocating manufacturing of pharmaceuticals and medical supplies and devices to the United States - Provisions related to prescription drug supply chains and manufacturing tax incentives Trade Agreements including USMCA and related policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain and China Task Force policy issues
Client expense: $1,210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2020 · third_quarter · Health Issues
COVID-19 pandemic response and supply chain issues; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2020 · third_quarter · Health Issues
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531).
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · third_quarter · Labor Issues/Antitrust/Workplace
Lobbied on the confirmations of Chad Bungard, Dennis Dean Kirk, and Julia Clark to serve on the MSPB. Lobbied against confirmation of Catherine Bird to be General Counsel of FLRA. Lobbied against confirmation of John Gibbs to be director of the Office of Personnel Management. Lobbied against any attempts the expand the Department of Veterans Affairs' Accountability and Whistleblower Protection Act government-wide. Lobbied in support of H.R. 1254, the "Equal COLA Act," to achieve parity between the cost of living adjustment to an annuity under the Federal Employees Retirement System and an annuity under the Civil Service Retirement System. Lobbied in support of S. 165, the "Federal Unemployment Compensation Equality Act of 2019," to amend current law to clarify that Federal employees excepted from a furlough are eligible for unemployment compensation. Lobbied in support of S. 222, to require payment of interest on back pay for employees affected by a lapse in appropriations. Lobbied in support of H.R. 953, to help prevent negative credit reporting due to a government shutdown. Lobbied in support of S. 464, Protecting Employees' Security Clearances Act (PESCA), which requires consideration of a lapse in appropriations as a mitigating condition when assessing financial consideration for security clearances. Lobbied in support of H.R. 5690/S. 3231, the "Federal Adjustment of Income Rates Act" to provide federal employees with a 3.5% salary adjustment in 2021. Lobbied in support of S. 521 and H.R. 141, Social Security Fairness Act, to repeal the government pension offset and windfall elimination provisions. Lobbied in support of S. 530 and H.R. 1316, the "Federal Labor-Management Partnership Act," to establish the Federal Labor-Management Partnership Council. Lobbied in support of S. 24, Government Employee Fair Treatment Act of 2019, so employees of the federal government or a District of Columbia public employer who are furloughed or required to work during a lapse in appropriations beginning on or after December 22, 2018, to be compensated for the period of the lapse. Lobbied in support of H.R. 7, the "Paycheck Fairness Act," To amend the "Fair Labor Standards Act of 1938" to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex, and for other purposes. Lobbied against H.R. 605, Official Time Reporting Act, to require that the Office of Personnel Management submit an annual report to Congress relating to the use of official time by Federal employees. Lobbied for H.R. 1309, Workplace Violence Prevention for Health Care and Social Service Workers Act, to require DOL to address workplace violence in the health care and social service sectors Lobbied for H.R. 582, Raise the Wage Act, to increase the federal minimum wage for regular employees over a 7-year period, for tipped employees, and for newly hired employees who are less than 20 years old. Lobbied in support of H.R. 4328, the "Protecting Innocent Consumers Affected by the Shutdown Act of 2019." Lobbied Education and Labor Committee on collective bargaining contract effects on the Education workforce and Secretary's actions to alter the Department's work on student loans and civil rights enforcement. Lobbied in support of H.R. 3463/S. 1970, the "Public Service Freedom to Negotiated Act." Lobbied in support of H.R. 2474/S. 1306, the "Protecting the Right to Organize Act." Lobbied against the nomination of Keith Sonderling (R) and Andrea Lucas (R) nominees for the EEOC. Lobbied in support of Jocelyn Samuels (D) nominee for the EEOC. Lobbied for passage of H.R. 7574, the "Strengthening America's Strategic National Stockpile Act of 2020." FY 2020 Emergency Supplemental Coronavirus Pandemic Response Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 925, the Heroes Act; H.R. 8015, the Delivering for America Act; and H.R. 8319 , the FY 2020 Continuing Appropriations and Other Extensions Act. FY 2020 Supplemental Appropriations - Lobbied for passage of H.R. 8337 making continuing appropriations for FY 2020 through December 11, 2020.
Client expense: $430,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Air Force, Dept of, Army, Dept of (Corps of Engineers), Army, Dept of (Other), Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense Commissary Agency, Defense Contract Audit Agency (DCAA), Defense Finance & Accounting Service (DFAS), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Coast Guard (USCG), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Marines, Veterans Affairs, Dept of (VA), Voice of America
2020 · third_quarter · Defense
Lobbied for support of provisions in H.R. 6395/S. 4049 the "National Defense Authorization for Fiscal Year 2021." Lobbied in support of Norcross Amendment, which became section 1102, Limitation on authority to exclude employees from chaper 71 of title 5, of the House NDAA bill, including retention of provision through Conference. This provision would defund implementation of any effort to excluded DoD or components of DoD from collective bargaining pursuant to chapter 71 of title 5. Lobbied in support of Larsen amendment 738 which became directive report language in the House NDAA pertaining to the contractor inventory, planning, programming and budgeting of services contracts and the impact this has on civilian reductions during Defense Wide Reviews. Lobbied in support of House NDAA bill language section 1106, Limiting the number of local wage areas defined within a pay locality. Lobbied in support of House NDAA bill language section 1101, Paid parental leave technical corrections, to cover federal employees who are currently ineligible because they are not title 5 employees. Lobbied in support of the Houlahan amendment, which because House NDAA section 911, Limitation on reduction of civilian workforce. Lobbied against the Pentagon Force Protection Agencys misuse of medical standards in a discriminatory manner in violation of various civil rights laws. Lobbied House Armed Services Committee regarding Ranking Member Thornberrys Acquisition Reform proposal that became section 806, Defense Reform, of the House NDAA bill to ensure mandated savings targets were excluded and that any reporting of savings with the budget not be the result of deferring requirements or assuming risk. Lobbied in support of sections 1121 through 1128 of the House NDAA bill reforming the federal employee workforce equal employment opportunity reforms of the process for investigating and adjudicating complaints. Lobbied in support of section 1808, COVID-19 Emergency Medical Supplies Enhancement, of the House NDAA bill, regulating the use of the Defense Production Act authorities for the manufacture and distribution of Personal Protective Equipment. Lobbied for passage of H.R. 7574, the "Strengthening America's Strategic National Stockpile Act of 2020." Lobbied in support of section 1111 of the House NDAA bill that includes pandemic leave as an exigency of public business for purposes of carrying over annual leave. Lobbied in support of sections 714, 715, 716 and 722 of the House NDAA bill, extending the DoD Health reorganization until 2025; extending the bar on reductions or realignment of military medical structure; requiring TRICARE quality standards be reported to Congress; and the development of a Departmental medical COVID-19 strategy. Lobbied in support of section 633 of the House NDAA bill, Updated business case analysis on consolidation of Defense Resale System. Lobbied in support of section 2702 of the Senate NDAA bill, Prohibition on conducting additional Base Realignment and Closure (BRAC). Lobbied against expanding public-private talent exchanges unless they contained limitations against contractors performing inherently governmental functions and enhanced public disclosure requirements for contractor employees detailed to perform federal government jobs. Lobbied against section 937 of the Senate NDAA bill, Applicability to Other Provisions of Law, that would exempt the Space Force from Title 5, 10, 18, 31, 37, 38 and 41. Lobbied against section 946 of the Senate NDAA bill that would expand the Acquisition Demonstration authority to Space Force acquisition personnel. Lobbied against various expansions of direct hire authority in the Senate NDAA bill sections 1106, 1108, 1109 and 1110. Lobbied against the expansion of commercial items in section 820 and 820C of the House NDAA bill. Lobbied against section 841 of the Senate NDAA bill that would provide broad authority to acquire commercial products and services using general solicitation competitive procedures. Lobbied against raising the Truth in Negotiations Act threshold in section 842 of the Senate NDAA bill. Lobbied against section 373 of the Senate NDAA bill that provides an exception to the title 10 United States Code section 2465 prohibition against contracting the security guard function in the case of the Army, Navy, Marine Corps and Air Force Museums. Lobbied in support of section 8012 of the House Defense Appropriations bill, prohibiting managing the DoD civilian workforce to personnel caps and requiring managing the DoD civilian workforce to budget and workload. Lobbied in support of continuation of the A-76 public-private competition moratorium. Lobbied in support of aligning wage grade pay localities with general schedule localities in section 736 of the Financial Services General Government Appropriation for FY 2021 in the House Bill. Lobbied in support of protecting collective bargaining on a government wide basis in section 741 of the Financial Services General Government Appropriation for FY 2021 in the House Bill. FY 2020 Emergency Supplemental Coronavirus Pandemic Response Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 925, the Heroes Act; H.R. 8015, the Delivering for America Act; and H.R. 8319 , the FY 2020 Continuing Appropriations and Other Extensions Act. FY 2020 Supplemental Appropriations - Lobbied for passage of H.R. 8337 making continuing appropriations for FY 2020 through December 11, 2020.
Client expense: $430,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Air Force, Dept of, Army, Dept of (Corps of Engineers), Army, Dept of (Other), Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Defense Commissary Agency, Defense Contract Audit Agency (DCAA), Defense Finance & Accounting Service (DFAS), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Transportation Security Administration (TSA), Transportation, Dept of (DOT), U.S. Coast Guard (USCG), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Marines, Veterans Affairs, Dept of (VA), Voice of America
2020 · third_quarter · Disaster Planning/Emergencies
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. State Opioid Response Grants funding for FY 2021. NDAA - provisions related to biological and chemical defense. Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Budget/Appropriations
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. State Opioid Response Grants funding for FY 2021. NDAA - provisions related to biological and chemical defense. Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Homeland Security
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. State Opioid Response Grants funding for FY 2021. NDAA - provisions related to biological and chemical defense. Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
COVID-19 pandemic response; issues related to the health care supply chain; Medical Supplies for Pandemics Act (H.R. 6531); Implementation of CARES Act (P.L. 116-136); Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2020 · third_quarter · Trade (domestic/foreign)
H.R. 2209: Fixing Global Freeloading Act - Provisions related to trade policy issues and international pharmaceutical drug pricing issues H.R. 4710: Pharmaceutical Independence Long-Term Readiness Reform Act - Provisions related to the supply chain H.R. 6049: Medical Supply Chain Security Act - Provisions related to prescription drug supply chains and drug safety H.R. 6482: Protecting Our Pharmaceutical Supply Chain from China Act of 2020 - Provisions related to prescription drug supply chains H.R. 6690: Bring Entrepreneurial Advancements To Consumers Here In North America Act - Provisions related to prescription drug supply chains and manufacturing tax incentives H.R. 6731: Securing America's Pharmaceutical Supply Chain Act - Provisions related to prescription drug supply chains H.R. 6879: Buy American Medical Supply Chain Act of 2020 - Provisions related to prescription drug and medical device supply chains H.R. 6930: MADE in America Act of 2020 - Provisions related prescription drug supply chains and manufacturing tax incentives H.R. 7492: To designate all of Puerto Rico as an opportunity zone - Provisions related to manufacturing incentives H.R. 7505: American Innovation Act of 2020: Provisions related to manufacturing tax incentives H.R. 7574: Strengthening America's Strategic National Stockpile Act of 2020 - Provisions related to medical supply chains H.R. 7955: 21st Century Buy American Act - Provisions related to federal domestic sourcing requirements S. 3343: Medical Supply Chain Security Act - Provisions related to prescription drug supply chains and drug safety S. 3478: To establish a commission to assess, evaluate, and address the dependence of the United States on medications, devices, and medical equipment from foreign countries - Provisions related to prescription drug supply chains and drug safety S. 3537: A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes - Provisions related to prescription drug supply chains and drug safety S. 3538: A bill to require the Secretary of Defense to submit to Congress a report on the reliance by the Department of Defense on imports of certain pharmaceutical products made in part or in whole in certain countries, to establish postmarket reporting requirements for pharmaceuticals, and for other purposes - Provisions related to prescription drug supply chains and drug safety S. 3635: Protecting Our Pharmaceutical Supply Chain from China Act of 2020 - Provisions related to prescription drug supply chains S. 3942: A bill to establish the position of Chief Pharmaceutical and Medical Supply Chain Negotiator in the Office of the United States Trade Representative, to be responsible for conducting trade negotiations and enforcing trade agreements related to acts, policies, and practices of foreign governments that fail to appropriately reward United States innovation with respect to pharmaceuticals, to advance domestic production of life-saving medicines, and to secure the United States medical supply chain to eliminate reliance on foreign governments, and for other purposes - Provisions related to prescription drug supply chains S. 3945: A bill to amend the Internal Revenue Code of 1986 to provide incentives for relocating manufacturing of pharmaceuticals and medical supplies and devices to the United States - Provisions related to prescription drug supply chains and manufacturing tax incentives Trade Agreements including USMCA and related policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain and China Task Force policy issues
Client expense: $5,960,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2020 · third_quarter · Health Issues
HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. S 2543 - Prescription Drug Pricing Reduction Act of 2019. S 551 - Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 HR 5238 - Better and Robust Screening Today Act S 2955 - Better and Robust Screening Today Act HR 3224 Deborah Sampson Act S 3343 - Medical Supply Chain Security Act S 3468 - Preventing Essential Medical Device Shortages Act of 2020 Defense Production Act for Ventilators COVID-19 response Energy and Water Appropriations Health and Human Services Appropriations Healthcare trade HR 7574 - Strengthening America's Strategic National Stockpile Act of 2020 HR 7956 - Critical Medical Infrastructure Right-to-Repair Act of 2020 S 4473 - Critical Medical Infrastructure Right-to-Repair Act of 2020
Client expense: $850,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Aeronautics & Space Administration (NASA), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2020 · third_quarter · Defense
NDAA - provisions related to biological and chemical defense HR 7574 - Strengthening America's Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy & Commerce)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Client expense: $209,625 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Free Trade Agreements - Intellectual Property and Transparency Provisions - Free Trade Agreements Access to Medicines Issues Global Health Issues India, China and Canada IP and Market Access Issues Sub-standards Medicines Quality of Medicines International Market Access and Intellectual Property Issues Biopharmaceutical Innovation Policies Regulatory Cooperation USTR Special 301 Report/National Trade Estimate Trade Policy Tariffs CFIUS USMCA US Swiss Trade Agreement Pharmaceutical supply chain H.R. 2209 - Fixing Global Freeloading Act H.R. 6049 - Medical Supply Chain Security Act H.R. 6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020 H.R. 6690 - Bring Entrepreneurial Advancements To Consumers Here In North America Act H.R. 6731 - Securing America's Pharmaceutical Supply Chain Act H.R. 6879 - Buy American Medical Supply Chain Act of 2020 H.R. 7492 - To designate all of Puerto Rico as an opportunity zone H.R. 7505 - American Innovation Act of 2020: Provisions related to manufacturing tax incentives H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 H.R. 7955 - 21st Century Buy American Act S. 3343 - Medical Supply Chain Security Act S. 3478 - To establish a commission to assess, evaluate, and address the dependence of the United States on medications, devices, and medical equipment from foreign countries S. 3537 - A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes S. 3942 - Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act S. 3945 - A bill to amend the Internal Revenue Code of 1986 to provide incentives for relocating manufacturing of pharmaceuticals and medical supplies and devices to the United States
Client expense: $1,190,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
2020 · third_quarter · Disaster Planning/Emergencies
Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2020 · third_quarter · Homeland Security
Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2020 · third_quarter · Budget/Appropriations
Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to H.R. 925 - The Heroes Act; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2020 · third_quarter · Homeland Security
H.R. 6395 and S. 4049 - National Defense Authorization Act for Fiscal Year 2021 - provisions related to biological and chemical defense; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) - provisions related to the development, acquisition and stockpiling of medical countermeasures for the U.S. government; H.R. 8406 - The HEROES Act - Supplemental Stimulus Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government; Initiatives and products to combat the opioid health crisis, including naloxone access and prescribing guidelines; H.R. 2466 - State Opioid Response Grant Authorization Act - entire bill; S. 4058 - Emergency Support for Substance Use Disorders Act - emergency grants for states and community organizations serving individuals with substance use disorder; H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 - entire bill.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE